Laura Shawver
2018 - Synthorx
In 2018, Laura Shawver earned a total compensation of $5.2M as President and Chief Executive Officer at Synthorx, a 3,349% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $151,890 |
|---|---|
| Option Awards | $4,608,244 |
| Salary | $430,125 |
| Other | $24,468 |
| Total | $5,214,727 |
Shawver received $4.6M in option awards, accounting for 88% of the total pay in 2018.
Shawver also received $151.9K in non-equity incentive plan, $430.1K in salary and $24.5K in other compensation.
Rankings
In 2018, Laura Shawver's compensation ranked 1,904th out of 14,244 executives tracked by ExecPay. In other words, Shawver earned more than 86.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,904 out of 14,244 | 87th |
Division Manufacturing | 684 out of 5,759 | 88th |
Major group Chemicals And Allied Products | 226 out of 2,122 | 89th |
Industry group Drugs | 179 out of 1,811 | 90th |
Industry Pharmaceutical Preparations | 137 out of 1,385 | 90th |
Source: SEC filing on April 24, 2019.
Shawver's colleagues
We found two more compensation records of executives who worked with Laura Shawver at Synthorx in 2018.
News
ARS Pharmaceuticals CEO Laura Shawver's 2022 pay jumps 608% to $5.8M
May 1, 2023
ARS Pharmaceuticals CEO Laura Shawver's 2021 pay falls 94% to $822K
April 28, 2022
ARS Pharmaceuticals CEO Laura Shawver receives $14M in 2020
April 22, 2021
Synthorx CEO Laura Shawver's 2018 pay jumps 3,349% to $5.2M
April 24, 2019